FDA.reportPublic FDA data

estrogens, conjugated (USP) 0.9 MG Oral Tablet

RxCUI
197661
RxNorm name
estrogens, conjugated (USP) 0.9 MG Oral Tablet
Display name
Estrogens, conjugated (USP) (Oral Pill)
Full name
estrogens, conjugated (USP) 0.9 MG Oral Tablet
Term type
SCD
Status
Active
Strength
0.9 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-06 11:39:41

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
estrogens, conjugated (USP)0.9 MG / 1 EACHestrogens, conjugated (USP)estrogens, conjugated (USP)

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
estrogens, conjugated (USP)4099

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRestrogens, conjugated (USP) 0.9 MG Oral Tablet1NAMES
RxNorm Nameestrogens, conjugated (USP) 0.9 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI1976611CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
50742-390-0150742-390estrogens, conjugated estrogens, conjugatedIngenus Pharmaceuticals, LLCANDA214023
50742-390-1050742-390estrogens, conjugated estrogens, conjugatedIngenus Pharmaceuticals, LLCANDA214023
66993-298-0266993-298Conjugated Estrogens estrogens, conjugatedPrasco LaboratoriesNDA004782

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA21402350742-390estrogens, conjugated estrogens, conjugatedANDAIngenus Pharmaceuticals, LLC
NDA00478266993-298Conjugated Estrogens estrogens, conjugatedNDA AUTHORIZED GENERICPrasco Laboratories

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 38 matching rows.

NDC11, Source, Active table
NDC11SourceActive
50742039001rxnav_ndcsyes
50742039010rxnav_ndcsyes
66993029802rxnav_ndcsyes
00008110306rxnav_historical
00008110307rxnav_historical
00008110381rxnav_historical
00046086421rxnav_historical
00046086467rxnav_historical
00046086481rxnav_historical
00046110306rxnav_historical
00046110307rxnav_historical
00046110381rxnav_historical
00179177970rxnav_historical
00179177971rxnav_historical
00179177972rxnav_historical
00247024900rxnav_historical
00247024915rxnav_historical
00247024930rxnav_historical
00247024960rxnav_historical
00247024990rxnav_historical
26053013001rxnav_historical
33358029530rxnav_historical
51129383401rxnav_historical
51129383402rxnav_historical
54569084900rxnav_historical
54569084901rxnav_historical
54569851800rxnav_historical
54569851801rxnav_historical
54868036500rxnav_historical
54868036501rxnav_historical
54868036502rxnav_historical
54868036503rxnav_historical
57866798701rxnav_historical
58016074500rxnav_historical
62584086490rxnav_historical
66267090230rxnav_historical
67228011903rxnav_historical
67228011906rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
estrogens, conjugatedESTROGENS, CONJUGATEDIngenus Pharmaceuticals, LLC7277bab4-d8c2-4e4b-a0d9-5dfe1885d5472026-08-25Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 50742-390-01
ndc (package): 50742-390-10
ndc (product): 50742-390
ndc11 (package): 50742039001
ndc11 (package): 50742039010
rxcui: 197661
PremarinESTROGENS, CONJUGATEDWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.258e1602-a3cf-4ccc-ca80-73dbbfb812ff2026-06-04Boxed warning, Warnings, Adverse reactionsExact identifier
ndc11 (package): 00046110381
rxcui: 197661
Conjugated EstrogensESTROGENS, CONJUGATEDPrasco Laboratoriesce793f9e-0c20-43e6-9dc0-064e5c82e2432026-02-27Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 66993-298-02
ndc (product): 66993-298
ndc11 (package): 66993029802
rxcui: 197661

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b32fcb1b-fee4-44b8-a91c-10dfdd3f84eaestrogens, conjugated 0.9 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.9 MG Oral Tablet [SCD]2320140508
ce793f9e-0c20-43e6-9dc0-064e5c82e243estrogens, conjugated 0.9 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.9 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. Conjugated Estrogens Tablets, for oral use Initial U.S. Approval: 194220260227
7277bab4-d8c2-4e4b-a0d9-5dfe1885d547estrogens, conjugated 0.9 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.9 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets，for oral use Initial U.S. Approval: 194220251016

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
7277bab4-d8c2-4e4b-a0d9-5dfe1885d547These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets，for oral use Initial U.S. Approval: 1942Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd.20260825
258e1602-a3cf-4ccc-ca80-73dbbfb812ffThese highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company20260604
ce793f9e-0c20-43e6-9dc0-064e5c82e243These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. Conjugated Estrogens Tablets, for oral use Initial U.S. Approval: 1942Prasco Laboratories | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company20260227
258e1602-a3cf-4ccc-ca80-73dbbfb812ffThese highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company20260220
7277bab4-d8c2-4e4b-a0d9-5dfe1885d547These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets，for oral use Initial U.S. Approval: 1942Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd.20251016
b32fcb1b-fee4-44b8-a91c-10dfdd3f84eaPhysicians Total Care, Inc.20140508
52817aab-c22b-4d5a-9b09-cacb9bbed044National Council for Prescription Drug Programs20120724
77c93709-6d08-463a-8514-31f7264f90ddNational Council for Prescription Drug Programs20120724
9125c986-1340-43e6-9a32-9b1cf377c5d7National Council for Prescription Drug Programs20120724
dc67c4f9-5fff-49c8-8de5-ba1ba7aba7fdNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCG03CANatural and semisynthetic estrogens, plainATC1-4estrogens, conjugated (USP)
FDASPLD004966Estrogens, Conjugated (USP)CHEMhas_chemical_structureestrogens, conjugated (USP)
FDASPLN0000175825EstrogenEPChas_epcestrogens, conjugated (USP)
FDASPLN0000000100Estrogen Receptor AgonistsMOAhas_moaestrogens, conjugated (USP)
MEDRTD004966Estrogens, Conjugated (USP)CHEMhas_ingredientestrogens, conjugated (USP)
MEDRTD020152Antithrombin III DeficiencyDISEASEci_withestrogens, conjugated (USP)
MEDRTD001943Breast NeoplasmsDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD001943Breast NeoplasmsDISEASEci_withestrogens, conjugated (USP)
MEDRTD004342Drug HypersensitivityDISEASEci_withestrogens, conjugated (USP)
MEDRTD006470HemorrhageDISEASEci_withestrogens, conjugated (USP)
MEDRTD019584Hot FlashesDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD007006HypogonadismDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD008107Liver DiseasesDISEASEci_withestrogens, conjugated (USP)
MEDRTD008594Menopause, PrematureDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD008595MenorrhagiaDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD009376Neoplasms, Hormone-DependentDISEASEci_withestrogens, conjugated (USP)
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_preventestrogens, conjugated (USP)
MEDRTD011247PregnancyDISEASEci_withestrogens, conjugated (USP)
MEDRTD016649Primary Ovarian InsufficiencyDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD011471Prostatic NeoplasmsDISEASEmay_treatestrogens, conjugated (USP)
MEDRTD011655Pulmonary EmbolismDISEASEci_withestrogens, conjugated (USP)
MEDRTD013923ThromboembolismDISEASEci_withestrogens, conjugated (USP)
MEDRTD013924ThrombophlebitisDISEASEci_withestrogens, conjugated (USP)
MEDRTD020246Venous ThrombosisDISEASEci_withestrogens, conjugated (USP)
MEDRTN0000000100Estrogen Receptor AgonistsMOAhas_moaestrogens, conjugated (USP)
MEDRTN0000008311Bone Formation StimulationPEhas_peestrogens, conjugated (USP)
MEDRTN0000009051Gonadotropin Releasing Hormone AlterationPEhas_peestrogens, conjugated (USP)
MEDRTN0000009065Hematologic Activity AlterationPEci_peestrogens, conjugated (USP)
MEDRTN0000009805Pituitary Gland Activity AlterationPEhas_peestrogens, conjugated (USP)
MEDRTN0000009902Vaginal Function AlterationPEhas_peestrogens, conjugated (USP)
MEDRTN0000000026Hepatic MetabolismPKhas_pkestrogens, conjugated (USP)
MEDRTN0000000042Renal ExcretionPKhas_pkestrogens, conjugated (USP)

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.9 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA214023
CODESSNOMEDCT409116005
CODESVUID4004640
NAMESPrescribable Synonymestrogens, conjugated 0.9 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File